EP4055365 - CHARACTERIZATION OF PARTICLES IN SOLUTION [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 08.12.2023 Database last updated on 06.07.2024 | |
Former | Request for examination was made Status updated on 12.08.2022 | ||
Former | The international publication has been made Status updated on 14.05.2021 | ||
Former | unknown Status updated on 10.11.2020 | Most recent event Tooltip | 12.06.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states NanoTemper Technologies GmbH Flössergasse 4 81369 München / DE | [2022/37] | Inventor(s) | 01 /
BAASKE, Philipp Kleinstr. 30 81379 München / DE | 02 /
DERIX, Jonathan Hauptstr. 35c 85716 Unterschleißheim / DE | 03 /
HASLINGER, Robert Hoflacher Straße 87 82223 Eichenau / DE | [2022/37] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstraße 3 81675 München / DE | [2022/37] | Application number, filing date | 20800216.2 | 06.11.2020 | [2022/37] | WO2020EP81370 | Priority number, date | EP20190208187 | 08.11.2019 Original published format: EP 19208187 | EP20200197910 | 23.09.2020 Original published format: EP 20197910 | [2022/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021089834 | Date: | 14.05.2021 | Language: | EN | [2021/19] | Type: | A1 Application with search report | No.: | EP4055365 | Date: | 14.09.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.05.2021 takes the place of the publication of the European patent application. | [2022/37] | Search report(s) | International search report - published on: | EP | 14.05.2021 | Classification | IPC: | G01N15/02, G01N15/00, G01N21/51, G01N33/68 | [2022/37] | CPC: |
G01N21/6486 (EP,KR,US);
G01N15/0211 (EP,KR,US);
G01N33/6803 (US);
G01N15/01 (EP,KR,US);
G01N21/51 (EP,KR);
G01N33/68 (EP,KR);
G01N2015/0038 (EP,KR,US);
G01N2015/0092 (EP,KR,US);
G01N2015/019 (EP,KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/37] | Title | German: | CHARAKTERISIERUNG VON TEILCHEN IN LÖSUNG | [2022/37] | English: | CHARACTERIZATION OF PARTICLES IN SOLUTION | [2022/37] | French: | CARACTÉRISATION DE PARTICULES EN SOLUTION | [2022/37] | Entry into regional phase | 08.06.2022 | National basic fee paid | 08.06.2022 | Designation fee(s) paid | 08.06.2022 | Examination fee paid | Examination procedure | 08.06.2022 | Examination requested [2022/37] | 08.06.2022 | Date on which the examining division has become responsible | 30.12.2022 | Amendment by applicant (claims and/or description) | 12.12.2023 | Despatch of a communication from the examining division (Time limit: M06) | 12.06.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 23.11.2022 | Renewal fee patent year 03 | 22.11.2023 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]US5575977 (MCKINNEY DAVID K [US], et al) [Y] 4,25,37 * column 15, line 1 - line 47; figure 3 *; | [XAYI]US5973779 (ANSARI RAFAT R [US], et al) [X] 1,3,5,6,9,13,14,17-21,26,28,30 * column 1, line 8 - line 34 * * column 6, line 38 - line 43; figure 1 * * column 8, line 1 - line 63; figure 2 * * column 13, line 26 - line 45; figures 10,11(a),11(b) * * column 14, line 57 - column 15, line 3 * [A] 10-12,29 [Y] 4,25,37 [I] 2,7,8,15,16,21,23-25,27,31-36,38,39; | [YA]FR2856792 (COMMISSARIAT ENERGIE ATOMIQUE [FR]) [Y] 4 * page 9, line 27 - page 10, line 16 * [A] 3; | [XAI]US2010136611 (MAURER ELISABETH [CA]) [X] 1,2,5,6,9,13,16,18,26,30 * paragraphs [0005] , [0011] , [0021] , [0045] - [0047] - [0054] , [0065] , [0068] , [0089]; figures 1A,1B,2 * [A] 3,4,29 [I] 7,8,10-12,14,15,17,19-25,27,28,31-39; | [XAI]EP3159674 (EUROPEAN MOLECULAR BIOLOGY LABORATORY [DE], et al) [X] 1,2,5,6,8-19,27,28,30-33,35,39 * paragraphs [0001] , [0005] , [0015] , [0027] , [0036] , [0037] , [0044] , [0051] , [0078] , [0080] , [0086] , [0089]; figure 1 * [A] 3,4,29,34 [I] 7,20-26,36-38; | [A]US2018259535 (VERDINE GREGORY L [US], et al) [A] 25,37 * paragraph [0596] *; | [XYI]US2018313758 (HSIEH VINCENT [US], et al) [X] 1-3,5,6,9-13,16-18,26-32,34,35,38,39 * paragraphs [0008] , [0010] , [0015] , [0022] , [0026] , [0027] , [0037] , [0048]; figure 5 * [Y] 4,25,37 [I] 7,8,14,15,19-25,33,36; | [A]WO2019166650 (CDR LIFE AG [CH]) [A] 25,37 * paragraph [0221] *; | [A]WO2019201894 (MERCK PATENT GMBH [DE]) [A] 25,37* page 8, line 34 - line 36 * |